Finance

Lists
Why is 688606 down 2,03%?
Dive Deeper
688606:SHA
Hangzhou Alltest Biotech Co Ltd
CN¥46,78
-2,03%
(-0,97) 1D
15 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688606...
Open
CN¥47,48
High
CN¥47,97
Low
CN¥46,53
Mkt. cap
3,69 mjd
Avg. vol.
316,57 k
Volume
386,42 k
Dividend
4,28%
Quarterly dividend
CN¥0,50
Ex-dividend date
01 Jun. 2026
P/E ratio
26,77
52-wk high
CN¥72,88
52-wk low
CN¥39,80
EPS
CN¥1,75
No. of employees
960
Open
CN¥47,48
High
CN¥47,97
Low
CN¥46,53
Mkt. cap
3,69 mjd
Avg. vol.
316,57 k
Volume
386,42 k
Dividend
4,28%
Quarterly dividend
CN¥0,50
Ex-dividend date
01 Jun. 2026
P/E ratio
26,77
52-wk high
CN¥72,88
52-wk low
CN¥39,80
EPS
CN¥1,75
No. of employees
960
News stories
From web sources and news partners
About Hangzhou Alltest Biotech Co Ltd
CEO-
Employees960
Founded17 Apr. 2009
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
203,23 m
272,27 m
195,37 m
196,77 m
Cost of goods sold
89,68 m
171,15 m
91,99 m
92,97 m
Cost of revenue
89,68 m
171,15 m
91,99 m
92,97 m
Research and development expenses
26,02 m
35,10 m
28,75 m
31,64 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41,16 m
44,86 m
36,47 m
33,87 m
Operating expense
47,19 m
103,62 m
73,22 m
70,60 m
Total operating expenses
136,87 m
274,76 m
165,21 m
163,57 m
Operating income
66,36 m
-2,49 m
30,17 m
33,20 m
Other non operating income
-4,55 m
3,58 m
-19,03 m
18,08 m
EBT including unusual items
66,14 m
32,93 m
21,76 m
32,26 m
EBT excluding unusual items
68,37 m
-12,92 m
16,13 m
27,49 m
Income tax expense
8,52 m
2,58 m
2,63 m
751,83 k
Effective tax rate
12,88%
7,84%
12,08%
2,33%
Other operating expenses
-22,23 m
27,73 m
4,68 m
5,77 m
Net income
57,80 m
30,38 m
19,39 m
31,45 m
Net profit margin
28,44%
11,16%
9,93%
15,98%
Earnings per share
-
-
-
-
Interest and investment income
7,19 m
-
5,20 m
8,32 m
Interest expense
-147,09 k
-1,06 m
-206,80 k
-
Net interest expenses
7,05 m
-1,06 m
5,00 m
8,32 m
Depreciation and amortization charges
-
-
-
-
EBITDA
72,82 m
7,39 m
40,05 m
44,32 m
Gain or loss from assets sale
-
-616,68 k
-
-65,17 k
AI content may include mistakes. Learn more
Google-programme